Skip to main content
. 2016 Jun 11;32(5):733–741. doi: 10.1007/s00467-016-3399-0

Fig. 2.

Fig. 2

Methylmalonic aciduria and homocystinuria, cobalamine C (cblC) complementation type (MMACHC) mutations in patients with renal thrombotic microangiopathy (TMA). Protein prediction is depicted for all identified MMACHC mutations, except for the splice changes, which are indicated at the complementary DNA (cDNA) level